OMER Q2 2017 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M+71.4% YoY

Gross Profit

$17M99.1% margin

Operating Income

-$12M-69.6% margin

Net Income

-$14M-83.7% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+39.9%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$60M

Total Liabilities

$115M

Stockholders' Equity

-$55M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$10M	+71.4%
Gross Profit	$17M	$10M	+75.6%
Operating Income	-$12M	-$11M	-9.2%
Net Income	-$14M	-$13M	-13.9%